Site icon OncologyTube

NEOD001 Leads to Several Phase 2 and Phase 3 Trials

Jason Valent, MD of Cleveland Clinic discusses how NEOD001 leads to clinical trials at the 58th ASH Annual Meeting in San Diego, CA.

Exit mobile version